The progesterone receptor (PgR) is strongly associated with disease prognosis and therapeutic efficacy in hormone-related diseases such as endometriosis, breast, ovarian, and uterine cancers [55], while androgen receptors (AR) play a fundamental role in the development and survival of male reproductive tissues, such as the prostate [56]. This evidence concerns the gene AR and uterine cancer.